Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Metabolon
AddedFeb 15, 2024
UpdatedJun 18, 2026
Metabolon

Metabolon

Public

Metabolon, based in Durham, US, leads in metabolomics for biomarker discovery, diagnostics & precision medicine.

HQ
Durham, NC, US
Founded
2000
Overview
Compare
Fundraising
Employees
Website

Metabolon, founded in Durham, United States, is a pioneering company in the field of metabolomics. Their core mission is to advance biomarker discovery, diagnostic testing, and precision medicine through their powerful phenotyping technology. Metabolon offers comprehensive metabolomics services that provide deep insights into biological systems, aiding in the development of new diagnostics and therapeutic strategies. Their market focus includes healthcare, pharmaceuticals, and biotechnology sectors.

Notable figures affiliated with Metabolon include a team of over 45 PhDs and a history of collaboration with leading research institutions. The company has completed over 10,000 projects and has been cited in more than 3,000 publications. Metabolon's key achievements include significant contributions to biomarker discovery and precision medicine, impacting both clinical research and patient care. Their work has established them as a global leader in metabolomics, driving innovation and improving health outcomes worldwide.

Metabolon - Similar Companies

Molecular Biometrics logo

Molecular Biometrics

Panome Bio logo

Panome Bio

panomebio.com

Phenomix Sciences logo

Phenomix Sciences

Quanterix logo

Quanterix

Genomind logo

Genomind

genomind.com

Matrix-Bio logo

Matrix-Bio

Attometrics logo

Attometrics

Microbiome Therapeutics logo

Microbiome Therapeutics

Precision Biologics logo

Precision Biologics

Sapient logo

Sapient

sapient.bio

BioAnalytics logo

BioAnalytics

Delve Bio logo

Delve Bio

delve.bio

Phdx logo

Phdx

Foundation Medicine logo

Foundation Medicine

Genomenon logo

Genomenon

genomenon.com

Metabolon - Quick Facts

Who are Metabolon's competitors?

Companies similar to Metabolon include Molecular Biometrics, Panome Bio, Phenomix Sciences and Quanterix.

When was Metabolon founded?

Metabolon was founded in 2000.

Where is Metabolon's headquarters located?

Metabolon's headquarters is located in Durham, NC, US.

When was Metabolon's last funding round?

Metabolon's most recent funding round was for $25M (USD) in January 2023.

How much has Metabolon raised to-date?

As of Jan 24, 2023, Metabolon has raised a total of $199.7M (USD).

How many employees does Metabolon have?

Metabolon has 302 employees as of Feb 5, 2024.

Metabolon - Classification

Ownership
  • Public
Technology
  • Analytics
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Biomarkers
  • Diagnostics
Tags
  • Biotech
  • Data Information
  • Healthcare
  • Healthtech
NAICS
  • 621000Ambulatory Health Care Services
  • 621500Medical and Diagnostic Laboratories
  • 621510Medical and Diagnostic Laboratories
  • 621511Medical Laboratories
  • 620000Health Care and Social Assistance
SIC
  • 8070Medical And Dental Laboratories
  • 8071Medical Laboratories
  • 8000Health Services
ISIC
  • 8690Other human health activities
Show 5 more industry codes
NAICS
  • 621512Diagnostic Imaging Centers
  • 623000Nursing and Residential Care Facilities
SIC
  • 6000Depository Institutions
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified